InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
+$0.35 today
- Market cap
- $293.89M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
Volume 0.16M
Average 0.16M
INFU Pre-Tax Margin
Income before tax as a percentage of revenue.
InfuSystem Holdings, Inc.AMEX: INFU
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin widens to 4.2%
Pre-tax margin was 4.2% in Q1 FY2026, up 3.5 pp from a year earlier. On a trailing-twelve-month basis it was 8.3%, up 3.5 pp year over year. Over 3 fiscal years it widened by 7.3 pp.
Context
- Pre-tax margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 7.4%
- Year-over-year change
- +3.7pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.4% | +3.7pp |
| FY2024 | 2024-12-31 | 3.8% | +2.3pp |
| FY2023 | 2023-12-31 | 1.5% | +1.4pp |
| FY2022 | 2022-12-31 | 0.1% | -1.1pp |
| FY2021 | 2021-12-31 | 1.2% | — |
Pre-Tax Margin vs competitors
How INFU compares with its peers on the latest reported figures
- INFU's LTM Mar 2026 pre-tax margin of 8.3% is the highest of the 3 companies compared; the peer median is -2.7%.
- Its year-over-year change of +3.5 pp is the 2nd highest of 3, against a peer median of +4.5 pp.
- Over three fiscal years its change of +7.3 pp compares with a peer median of +18.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 8.3% | +3.5 pp | +7.3 pp | |
| LTM Jun 2026 | -0.2% | -0.8 pp | +5.2 pp | |
| LTM Mar 2026 | -5.2% | +9.9 pp | +31.9 pp | |
| Peer median (excluding INFU) | -2.7% | +4.5 pp | +18.5 pp | |
Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 102.38M | 109.91M | 125.79M | 134.86M | 143.44M |
| Cost of Revenue | 43.85M | 49.35M | 62.68M | 64.46M | 63.14M |
| Gross Profit | 58.54M | 60.56M | 63.11M | 70.4M | 80.3M |
| Gross Margin | 57.2% | 55.1% | 50.2% | 52.2% | 56.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 51.45M | 56.41M | 58.03M | 62.52M | 67.46M |
| Operating Expenses | 55.72M | 58.91M | 59.02M | 63.51M | 68.38M |
| Depreciation & Amortization | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M |
| EBITDA | 17.26M | 14.89M | 16.53M | 20.03M | 25.22M |
| EBITDA Margin | 16.9% | 13.5% | 13.1% | 14.9% | 17.6% |
| Operating Income | 2.82M | 1.65M | 4.09M | 6.89M | 11.92M |
| Operating Margin | 2.8% | 1.5% | 3.2% | 5.1% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.38M | 1.4M | 2.17M | 1.78M | 1.3M |
| Other Income / Expenses | (1.56M) | (1.52M) | (2.24M) | (1.83M) | (1.3M) |
| Income Before Tax | 1.26M | 130K | 1.85M | 5.06M | 10.62M |
| Pre-Tax Margin | 1.2% | 0.1% | 1.5% | 3.8% | 7.4% |
| Income Tax Expense | (163K) | 112K | 979K | 2.71M | 4M |
| Net Income | 1.42M | 18K | 872K | 2.35M | 6.63M |
| Net Margin | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% |
| EPS (Basic) | 0.07 | 0.00 | 0.04 | 0.11 | 0.32 |
| EPS (Diluted) | 0.06 | 0.00 | 0.04 | 0.11 | 0.31 |
| Weighted Avg Shares | 20.52M | 20.65M | 21.02M | 21.27M | 20.66M |
| Weighted Avg Shares (Diluted) | 22.05M | 21.55M | 21.65M | 21.71M | 21.1M |
InfuSystem Holdings, Inc.
AMEX:INFU
Intrinsic Alpha fair value
Locked
Current Price
$14.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.